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Measurement of 17-hydroxyprogesterone (17-OHP) in
daily dried blood spot profiles via radioimmunoassay is
a convenient and accepted method for monitoring of
glucocorticoid therapy in Congenital Adrenal Hyperpla-
sia. Characteristics of this method that serve to limit its
clinical usefulness include its lack of specificity for
17-OHP, and a relatively high limit of detection. Mass
Spectroscopy is the gold standard method for steroid
quantification. We aim to establish a High Performance
Liquid Chromatography-Tandem Mass Spectroscopy
(HPLC-MS/MS) method for dried blood spot 17-OHP
quantification and develop normative age- and tanner-
specific, as well as Congenital Adrenal Hyperplasia gen-
otype-phenotype correlated reference ranges to guide
glucocorticoid therapy.
Four 3mm blood spots were punched from patient
dried blood spot filter paper specimens. 17-OHP was
eluted into solvent and concentrated using liquid nitro-
gen. Steroids were separated using high performance
liquid chromatography and quantitated by Tandem
Mass Spectrometry. For the radioimmunassay/HPLC-
MS/MS correlations, measurements were performed by
both methods on 49 samples from children with gluco-
corticoid-dependent Congenital Adrenal Hyperplasia, as
well as children undergoing dynamic endocrine function
testing at The Mater Children’s Hospital. Reference
samples for HPLC-MS/MS calibration, and determina-
tion of sensitivity, precision, and recovery were prepared
using whole blood samples spiked with 17-OHP spotted
onto filter paper. Concentrations were expressed as
mean (nmol/L), standard deviation, and coefficient of
variation (%).
There was excellent correlation between HPLC-MS/
MS and radioimmunoassay methods (r2=0.9610). For
the radioimmunoassay method, the lower limit of quan-
tification has been established at <5 nmol/L while
LC-MS/MS allows detection to 1.0 nmol/L (1.2nmol/L,
0.26, 22%) with a proposed lower limit of quantification
of 1.5 nmol/L (1.3 nmol/L, 1.3, 13%).
We have established an accurate, reliable, and specific
method for quantifying 17-OHP concentrations from
dried blood spot using HPLC-MS/MS. This will allow for
the establishment of clinically relevant and time-specific
reference ranges to guide glucocorticoid dose adjustment
in children with Congenital Adrenal Hyperplasia.
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